These findings as well as our study demonstrating the reduced expression of genes involved in the NOTCH pathway in MYCN-amplified cell lines and primary tumors, point toward a possible antagonistic relationship between MYCN and the NOTCH pathway components in these NB tumors, but not in the non-MYCN-amplified NB expressing MYC. Here, MYCN is linked to neuroblastoma.